Loading chat...
MN HF2637
Bill
Status
3/20/2019
Primary Sponsor
Alice Mann
Click for details
AI Summary
-
Amends Minnesota Statutes 2018, section 62J.23, subdivision 2, to clarify that "prescription drug" includes prescription drugs administered through infusion, along with related services and supplies.
-
Allows individuals to receive discounts, price reductions, or limited-time free supplies of prescription drugs (including infusion drugs), medical supplies, or medical equipment from manufacturers, health plan companies, or pharmacy benefit managers, subject to specified conditions.
-
Permits pharmaceutical manufacturers and device manufacturers to provide ancillary products necessary for treatment at discounted, reduced, or no cost, and to provide trinkets or mementos of insignificant value to patients.
-
Maintains prohibition on benefits, rewards, remuneration, or incentives for continued product use, with exceptions for activities permitted under existing discount provisions and ancillary product assistance.
-
Does not prohibit health plan companies from offering tiered formularies with different co-payment or cost-sharing amounts for different drugs.
Legislative Description
Provider conflict of interest restrictions for infusion drugs exemption provided.
Last Action
Introduction and first reading, referred to Commerce
3/20/2019